ELIZABETH BLANZY: Open Payments
NPI 1306580261 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,936 in 183 payments from 20 companies in 2025. Trend: 2023 $2,000 · 2024 $3,291 · 2025 $3,936
Food & beverage: $3,738Education: $198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $918 |
| Amgen Inc. | 51 | $722 |
| Janssen Biotech, Inc. | 20 | $477 |
| Novartis Pharmaceuticals Corporation | 22 | $460 |
| GENZYME CORPORATION | 16 | $293 |
| UCB, Inc. | 7 | $211 |
| Actelion Pharmaceuticals US, Inc. | 2 | $121 |
| Organon LLC | 4 | $99 |
| ANI Pharmaceuticals, Inc. | 3 | $79 |
| PFIZER INC. | 4 | $78 |
Products named: RINVOQ, TREMFYA, COSENTYX, KEVZARA, SKYRIZI, EVENITY, Bimzelx, OTEZLA.
Industry payments across MI — which companies pay providers there.
